ArticleTranslational lung cancer research2024

Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study.

Jialong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.